This post was originally published on this site
The deal would settle more than 3,000 lawsuits filed by state and local governments, but complete terms of the settlement are still being chalked out, according to the report. Thousands of lawsuits have been filed against drugmakers, distributors and pharmacies over the U.S. opioid crisis.
Israel-based Teva Pharmaceutical Industries (NYSE:TEVA) on Tuesday announced a $4.35 billion proposed nationwide settlement of its U.S. opioid lawsuits.
AbbVie did not immediately respond to a Reuters request for a comment.
